Prot #STM-01-C-001: A Phase 1, Open Label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

Project: Research project

Project Details

StatusActive
Effective start/end date11/20/24 → 11/20/27

Funding

  • Secretome Therapeutics, Inc. (Prot #STM-01-C-001)